The skyrocketing prices of medicines in Nigeria, fueled by the steep depreciation of the naira and the exit of GlaxoSmithKline, are causing severe hardships for patients who can no longer afford essential medications. Some drugs have seen prices surge almost tenfold in recent months, forcing patients to reduce their doses or seek alternative, traditional remedies due to financial constraints. The lack of health insurance coverage for the majority of Nigerians exacerbates the problem, with patients bearing the full financial burden of purchasing medications. The pharmaceutical industry, heavily reliant on imports, is grappling with challenges in sourcing affordable raw materials for drug production.
Soaring medicine prices in Nigeria prompt patients to cut doses or turn to traditional remedies.
